title: Evaluation and Management of Hearing Loss in Survivors of Childhood and Adolescent Cancers: A Report From the Children's Oncology Group.
abstract: Hearing loss (HL) is common in childhood cancer survivors exposed to platinum chemotherapy and/or cranial radiation and can severely impact quality of life. Early detection and appropriate management can mitigate academic, speech, language, social, and psychological morbidity resulting from hearing deficits. This review is targeted as a resource for providers involved in aftercare of childhood cancers. The goal is to promote early identification of survivors at-risk for HL, appropriate evaluation and interpretation of diagnostic tests, timely referral to an audiologist when indicated, and to increase knowledge of current therapeutic options.
authors.affiliation: Rehabiliation Services, St Jude Children's Research Hospital, Memphis, Tennessee.
authors.forename: Johnnie K
authors.initials: JK
authors.lastname: Bass
authors.affiliation: Child Development and Rehabilitation Center, Oregon Health and Science University, Portland, Oregon.
authors.forename: Kristin R
authors.initials: KR
authors.lastname: Knight
authors.affiliation: Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
authors.forename: Torunn I
authors.initials: TI
authors.lastname: Yock
authors.affiliation: Department of Otolaryngology, Stanford University, Stanford, California.
authors.forename: Kay W
authors.initials: KW
authors.lastname: Chang
authors.affiliation: Center for Cancer and Blood Diseases, Peyton Manning Children's Hospital at St. Vincent, Indianapolis, Indiana.
authors.forename: Douglas
authors.initials: D
authors.lastname: Cipkala
authors.affiliation: Pediatric Hematology-Oncology, Baystate Medical Center, Springfield, Massachusetts.
authors.forename: Satkiran S
authors.initials: SS
authors.lastname: Grewal
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D034381:Hearing Loss / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000628:therapy*; D017741:Survivors
keywords: cancer survivor; hearing loss; late effects; ototoxicity